[Federal Register Volume 62, Number 227 (Tuesday, November 25, 1997)]
[Notices]
[Pages 62778-62779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-30928]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting of the National 
Cancer Advisory Board and Its Subcommittees

    Pursuant to the Federal Advisory Committee Act, as amended, notice 
is hereby given of the meeting of the National Cancer Advisory Board 
(Board), National Cancer Institute (NCI), and its Subcommittees on 
December 2-3, 1997. The meetings of the Board and its Subcommittees 
will be open to the public as indicated below. Attendance by the public 
will be limited to space available.
    A portion of the Board meeting will be closed to the public in 
accordance with the provisions set forth in sections 552b(c)(6) and 
552b(c)(9)(B), Title 5 U.S.C. and section 10(d) of the Federal Advisory 
Committee Act, as amended, for discussions pertaining to NCI personnel 
and programmatic issues. These discussions could reveal information of 
a personal nature where disclosure would constitute a clearly 
unwarranted invasion of personal privacy and would be likely to 
significantly frustrate the subsequent implementation of personnel and 
programmatic recommendations made during these discussions.
    The Committee Management Office, National Cancer Institute, 
National Institutes of Health, Executive Plaza North, Room 609, 6130 
Executive Boulevard, MSC 7410, Bethesda, Maryland 20892-7410, (301) 
496-5708 will provide summaries of the meetings and rosters of the 
Board members, upon request.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Mrs. Linda Quick-Cameron, Committee Management Officer, at 
(301) 496-5708 in advance of the meeting.

    Name of Committee: National Cancer Advisory Board.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room

[[Page 62779]]

600, 6130 Executive Blvd., MSC MSC 7405, Bethesda, MD. 20892-7405, 
(301) 496-5147.
    Dates of Meeting: December 2-3, 1997.
    Place of Meeting: Building 31, Conference Room 10/C Wing, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD. 
20892.
    Open: December 2--8:30 a.m. to 4:00 p.m.; December 3--8:30 a.m. 
to 1:00 p.m.
    Agenda: Report of the Director, National Cancer Institute; 
Legislative Update; Report of the President's Cancer Panel; 
Subcommittee Reports; Overview of Board of Scientific Advisors 
activities. Intramural and Extramural Program Overviews and Updates. 
Presentations by various NCI working groups on current and proposed 
program activities, projects and initiatives; other NCAB business.
    Closed: December 2--4:10 p.m. to Recess.
    Agenda: Review and discussion of Intramural site visits, 
proprietary, programmatic and personnel issues. Review and 
discussion of Extramural proprietary, programmatic and personnel 
issues.
    This notice is being published less than 15 days to the meeting 
due to the urgent need to meet timing limitations imposed by the 
review and funding cycle.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.392, Cancer Detection and 
Diagnosis Research; 93.3394, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93:397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: November 18, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-30928 Filed 11-24-97; 8:45 am]
BILLING CODE 4140-01-M